semaglutide cardiovascular outcomes 2025 news today New in the May 29, 2025, issue of NEJM: Sotatercept in Pulmonary Arterial Hypertension (ZENITH phase 3 trial) https://nej.md/4iYkLbj Oral and (SOUL trial) https://nej.md/4hHII5M Upadacitinib for Giant-Cell Arteritis Cardiac Trials | Lowering CV
Description
New insights on consumers preferences on the texture of protein snacks create new opportunities for CPG companies Protein texture preferences Only about half of GLP-1 users are satisfied with protein options
Treating metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver fibrosis
An app designed specifically for GLP-1 users with AI food scanning, protein tracking, and dose logging in one place tends to work better than generic calorie apps
Hes the creator of Fortitude Training, author of Be Your Own Bodybuilding Coach , and a former national-level bodybuilding competitor, including winning the overall title at the 2009 NPC Mr
Jacob says patients often come in confused about why their faces no longer match their bodies
